These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25490421)

  • 1. Controlling molecular self-assembly: from amyloid oligomerization and therapy to novel biomaterials and technological applications in nanomedicine.
    Gazit E
    Nanomedicine (Lond); 2014 Nov; 9(16):2433-6. PubMed ID: 25490421
    [No Abstract]   [Full Text] [Related]  

  • 2. Preface: forum on frontiers and challenges in biomaterials.
    Reynolds MM; Fisher ER
    ACS Appl Mater Interfaces; 2013 Oct; 5(19):9247-8. PubMed ID: 24102341
    [No Abstract]   [Full Text] [Related]  

  • 3. Different fates of Alzheimer's disease amyloid-β fibrils remodeled by biocompatible small molecules.
    Irwin JA; Wong HE; Kwon I
    Biomacromolecules; 2013 Jan; 14(1):264-74. PubMed ID: 23157384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery.
    Sarvaiya J; Agrawal YK
    Int J Biol Macromol; 2015 Jan; 72():454-65. PubMed ID: 25199867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment.
    Oliva N; Unterman S; Zhang Y; Conde J; Song HS; Artzi N
    Adv Healthc Mater; 2015 Aug; 4(11):1584-99. PubMed ID: 25963621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility in regenerative nanomedicine.
    Zor F; Selek FN; Orlando G; Williams DF
    Nanomedicine (Lond); 2019 Oct; 14(20):2763-2775. PubMed ID: 31612774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-based nanosensors and nanodevices.
    Hauser CA; Maurer-Stroh S; Martins IC
    Chem Soc Rev; 2014 Aug; 43(15):5326-45. PubMed ID: 24781248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial biofabrication for nanomedicine: biomaterials, nanoparticles and beyond.
    Vázquez E; Villaverde A
    Nanomedicine (Lond); 2013 Dec; 8(12):1895-8. PubMed ID: 24279484
    [No Abstract]   [Full Text] [Related]  

  • 9. Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases. Study first to use 'structural' approach in hunt for amyloid-inhibiting agents.
    Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):642-3. PubMed ID: 24137741
    [No Abstract]   [Full Text] [Related]  

  • 10. From self-organizing polymers to nanohybrid and biomaterials.
    Förster S; Plantenberg T
    Angew Chem Int Ed Engl; 2002 Mar; 41(5):689-714. PubMed ID: 12491318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloids: not only pathological agents but also ordered nanomaterials.
    Cherny I; Gazit E
    Angew Chem Int Ed Engl; 2008; 47(22):4062-9. PubMed ID: 18412209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrathin silver nanowires produced by amyloid biotemplating.
    Malisauskas M; Meskys R; Morozova-Roche LA
    Biotechnol Prog; 2008; 24(5):1166-70. PubMed ID: 19194928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From self-assembly fundamental knowledge to nanomedicine developments.
    Monduzzi M; Lampis S; Murgia S; Salis A
    Adv Colloid Interface Sci; 2014 Mar; 205():48-67. PubMed ID: 24182715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering novel diagnostic modalities and implantable cytomimetic nanomaterials for next-generation medicine.
    Ho D; Fung AO; Montemagno CD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):92-9. PubMed ID: 16399592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization.
    Bitan G; Tarus B; Vollers SS; Lashuel HA; Condron MM; Straub JE; Teplow DB
    J Am Chem Soc; 2003 Dec; 125(50):15359-65. PubMed ID: 14664580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(citric acid)-block-poly(ethylene glycol) copolymers--new biocompatible hybrid materials for nanomedicine.
    Naeini AT; Adeli M; Vossoughi M
    Nanomedicine; 2010 Aug; 6(4):556-62. PubMed ID: 20074665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G; Ruchala P; Teplow DB
    Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role for pi-stacking in the self-assembly of amyloid fibrils.
    Gazit E
    FASEB J; 2002 Jan; 16(1):77-83. PubMed ID: 11772939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-Like Assembly to Form Film at Interfaces: Structural Transformation and Application.
    Han Q; Tao F; Yang P
    Macromol Biosci; 2023 Nov; 23(11):e2300172. PubMed ID: 37257459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancement in carbon nanotubes: basics, biomedical applications and toxicity.
    Beg S; Rizwan M; Sheikh AM; Hasnain MS; Anwer K; Kohli K
    J Pharm Pharmacol; 2011 Feb; 63(2):141-63. PubMed ID: 21235578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.